Market Introduction
The Middle East & Africa region includes countries such as South Africa, Saudi Arabia, the UAE, and the rest of MEA. The Middle East and Africa is considered to be an evolving market in terms of medical facilities and equipment and the demand for the product is rising in the region. The market for MEA is experiencing rapid development with the growth of markets such as Dubai, Abu Dhabi, and Iran. New investment in improved product offerings have led to the capture of market share in the Middle East and African Region. The shift in consumer lifestyles rising health consciousness along with rising instances of diabetes, kidney failures, respiratory issues and other such health concerns has triggered the demand for better health facilities in the region, which is eventually expected to stimulate the demand for the medical polyoxymethylene market. This has been providing huge opportunities for the manufacturers of the medical polyoxymethylene market. Also, emergence of applications in tissue engineering is the major factor driving the growth of the MEA medical polyoxymethylene market.
Saudi Arabia has the highest number of COVID-19 cases in the Middle East and Africa, followed by Turkey and UAE, among others. The UAE was the first country in the Middle East and Africa to report a confirmed case of COVID-19. The pandemic has affected economies and industries in various countries across MEA region due to lockdowns, travel bans, and business shutdowns. Chemical and materials is one of the major industries suffering serious disruptions in the form of supply chain breaks and production plants shutdowns. The shutdown of various manufacturing plants and factories in MEA region has hampered the global supply chain as well as manufacturing processes, delivery schedules, and goods sales. Various companies have already announced possible delays in product deliveries and projected the slump in future sales of their products. In addition, global travel bans imposed by MEA countries are affecting the business collaboration and partnership opportunities. These factors are making the conditions conducive for the growth of the food & beverages industry, alongside restraining the growth of other markets related to this industry. Therefore, the MEA medical polyoxymethylene market is facing difficulties to grow due to shortfall in production and insufficiency of transportation facilities.
Market Overview and Dynamics
The medical polyoxymethylene market in MEA is expected to reach US$ 5308.95 thousand by 2028 from US$ 4320.02 thousand in 2020. The market is estimated to grow at a CAGR of 2.6% from 2020 to 2028. The healthcare industry is expected to witness monumental transformation along with the factors such as rapid urbanization, rising instances of infectious diseases, and shift in consumer lifestyle. The demand for Medical POM has been rising in healthcare setting for sterilization of medical devices. However, the use of Medical POM is not limited to medical industry and has been expanding across diversified end use industries such as indoor air/HVAC applications along with building and construction, food & beverage, mold remediation, and packaging.
Key Market Segments
The MEA medical polyoxymethylene market is segmented into application, and country. On the basis of application, the MEA medical polyoxymethylene market is categorized into dialysis machine, handles for surgical instruments, inhalers, insulin pen, and others. Insulin pen segment dominated the market in 2019. Further, the inhalers segment is expected to be the fastest growing segment during the forecasted period.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the medical polyoxymethylene market in MEA are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are BASF SE; Celanese Corporation; DuPont de Nemours, Inc.; Korea Engineering Plastics Co., Ltd.; and Mitsubishi Chemical Corporation among others.
Reasons to buy report
MEA Medical Polyoxymethylene Market Segmentation
MEA Medical Polyoxymethylene Market -By Application
MEA Medical Polyoxymethylene Market -By Country
MEA Medical Polyoxymethylene Market -Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2020 | US$ 4320.02 thousand |
| Market Size by 2028 | US$ 5308.95 thousand |
| CAGR (2020 - 2028) | 2.6% |
| Historical Data | 2018-2019 |
| Forecast period | 2021-2028 |
| Segments Covered |
By Application
|
| Regions and Countries Covered |
Middle East and Africa
|
| Market leaders and key company profiles |
|
The Middle East and Africa Medical Polyoxymethylene Market is valued at US$ 4320.02 thousand in 2020, it is projected to reach US$ 5308.95 thousand by 2028.
As per our report Middle East and Africa Medical Polyoxymethylene Market, the market size is valued at US$ 4320.02 thousand in 2020, projecting it to reach US$ 5308.95 thousand by 2028. This translates to a CAGR of approximately 2.6% during the forecast period.
The Middle East and Africa Medical Polyoxymethylene Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Medical Polyoxymethylene Market report:
The Middle East and Africa Medical Polyoxymethylene Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Medical Polyoxymethylene Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Medical Polyoxymethylene Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)